Skip to content

The influence of binaural differential frequency music on anxiety and sedation during painless gastroscopy and colonoscopy

The influence of binaural differential frequency music on anxiety and sedation during painless gastroscopy and colonoscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111720
Enrollment
Unknown
Registered
2025-11-05
Start date
2025-11-05
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anxiety

Interventions

Binaural frequency difference music group:After putting on noise-cancelling headphones, play binaural differential frequency music for the clinical participants
Ordinary noise reduction group:Clinical subjects were fitted with noise-cancelling headphones without any additional intervention

Sponsors

General Hospital Of Eastern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–65 years; 2. ASA I, II, or III classification; 3. Clinical participants undergoing pain-free gastrointestinal endoscopy; 4. BMI >= 18.5 and < 28 kg/m².

Exclusion criteria

Exclusion criteria: 1. A history of severe heart, lung, brain, liver or kidney diseases; 2. History of chronic alcoholism and drug abuse; 3. Patients with neuromuscular diseases or mental illnesses; 4. Allergy to anesthetic drugs; 5. Difficult airway; 6. Patients who take oral angiotensin-converting enzyme inhibitors or oral angiotensin receptor blockers; 7. Patients who are unable to complete painless gastroscopy and colonoscopy; 8. Severe loss of sensory organs (such as vision or hearing impairment) and/or inability to communicate normally; 9. Thyroid dysfunction; 10. The patient refused.

Design outcomes

Primary

MeasureTime frame
The State Anxiety Scale (STAI-S) ;Visual Analogue Scale (VAS) for Pain;Pittsburgh Sleep Quality Index (PSQI);Dosage of cyclopofol during sedation;

Secondary

MeasureTime frame
Satisfaction of clinical participants;

Countries

China

Contacts

Public ContactKangli Hui

General Hospital Of Eastern Theater Command

17851181426qhw@sina.com+86 178 5118 1426

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026